Aviragen Therapeutics Revenue

Research Services • Alpharetta, Georgia, United States • 21-50 Employees

Aviragen Therapeutics revenue & valuation

Annual revenue	$2,741,000
Revenue per employee	$79,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$8,800,000
Total funding	No funding

Key Contacts at Aviragen Therapeutics

Meir Haber

Ceo

Behnam Osuli

Owner

Wouter Kerkman

Owner

Meir Haber

Ceo

Company overview

Headquarters	2500 Northwinds Parkway, Ste 100, Alpharetta, GA 30009, US
Phone number	+16505503500
Website	aviragentherapeutics.com
NAICS	5417
Keywords	Anti-Infective Drug Development
Founded	1984
Employees	21-50
Socials

Aviragen Therapeutics Email Formats

Aviragen Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 45.6% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	45.6%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	22.3%
{first name}@company.com	john@company.com	15.1%
{first name}{last name}@company.com	johndoe@company.com	9.8%
{first name}_{last name}@company.com	john_doe@company.com	7.2%

About Aviragen Therapeutics

Aviragen Therapeutics was acquired by Vaxart in 2017 and was focused on the discovery and development of the next generation of direct-acting antivirals to treat infections that have limited therapeutic options and affect a significant number of patients globally. The Company has three Phase 2 clinical stage compounds: vapendavir, a capsid inhibitor for the prevention or treatment of rhinovirus (RV) upper respiratory infections; enzaplatovir (BTA585), a fusion protein inhibitor in development for the treatment of respiratory syncytial virus infections; and BTA074, an antiviral treatment for condyloma caused by human papillomavirus types 6 & 11.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Aviragen Therapeutics has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Aviragen Therapeutics has never raised funding before.

Frequently asked questions

Aviragen Therapeutics is located in Alpharetta, Georgia, US.

You can reach Aviragen Therapeutics at +16505503500.

Aviragen Therapeutics generates an estimated annual revenue of $2,741,000. This revenue figure reflects the company's market position and business performance in its industry.

Aviragen Therapeutics has an estimated valuation of $8,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Aviragen Therapeutics was founded in 1984, making it 42 years old. The company has established itself as a significant player in its industry over this time.

Aviragen Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Aviragen Therapeutics

Meir Haber

Ceo

Behnam Osuli

Owner

Wouter Kerkman

Owner

Meir Haber

Ceo

4.8

40,000 users